The company’s cost-cutting initiative and pivot to medical cannabis could pay big dividends for patient shareholders.
The financial markets recently experienced a milestone event, with the Dow Jones Industrial Average reaching new peaks and the S&P 500 extending its bullish trend, now close to its two-year mark.
Amidst this bullish upswing, one industry has been steadily gaining attention — the cannabis industry. In 2024, cannabis stocks have not only matched but in many cases, surpassed the performance of these benchmark indices.
Image Source: Getty Images.
This year, investors have taken a particular interest in the cannabis industry, directing a fair amount of cash toward industry leaders like Aurora Cannabis (ACB -5.49%), Canopy Growth, Curaleaf Holdings, Green Thumb Industries, and Innovative Industrial Properties.
This cash infusion stems from two primary factors:
- Projected market growth: The global cannabis market is on…
